You're signed outSign in or to get full access.
Artia Global Partners LP
Artia Global Partners LP is a Miami-based hedge fund founded in or before 2022 and registered as an investment adviser. The firm manages assets for pooled investment vehicles and serves institutional investor clients, focusing on healthcare and biotech equities. As of 2025, it has 3 employees, the majority of whom are investment professionals. Artia Global Partners LP is registered with the SEC (CIK: 0001937964, CRD #322091) and manages several specialized funds such as the Artia Global Alpha Master Fund LP.
Investment Strategy
Artia Global Partners LP pursues a fundamentally driven investment strategy, focusing on U.S. and international equities, with a pronounced tilt toward the biotechnology and healthcare sectors. The firm seeks to identify undervalued companies through deep research and concentrated portfolio construction. Their investment philosophy emphasizes active management, capital preservation, and generating absolute returns for their investors by leveraging industry insights and disciplined risk control.
Latest 13F Filing Activity
Artia Global Partners LP filed their most recent 13F report on Jun 30, 2025 disclosing 33 equity positions and 1 options positions with a total 13F market value of $407M. The fund increased holdings in Verona Pharma PLC, Insmed Inc., Argenx SE among other positions. Artia Global Partners LP reduced exposure to Eli Lilly & Co., Intra-cellular Therapies Inc., Arcellx Inc. among others.
Top Holdings
Equity Positions (33)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
V VRNA | VERONA PHARMA PLC | 21.48% | $87.4M | 924,204 | $67.66 | $94.58 | +$53.2M |
I INSM | INSMED INC | 18.61% | $75.8M | 752,712 | $85.94 | $100.64 | +$51.5M |
A ARGX | ARGENX SE | 10.61% | $43.2M | 78,311 | $527.57 | $551.22 | +$36.5M |
S SLNO | SOLENO THERAPEUTICS INC | 10.18% | $41.4M | 494,424 | $46.60 | $83.78 | +$5.8M |
L LLY | ELI LILLY & CO | 5.88% | $23.9M | 30,700 | $825.91 | $779.53 | -$54.4M |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
I INSM | INSMED INC | New | Call | $4.0M | 400 | $100.64 | $100.64 | +400 | +$4.0M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more